What is the latest travel guidance and what does it mean for holidaymakers? halesowennews.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from halesowennews.co.uk Daily Mail and Mail on Sunday newspapers.
Assets expand immunology portfolio to include B-cell therapy and macrophage modulation - - IND-enabling studies are ongoing and will support the transition of these assets to clinical development in 20222023 - Aurinia Pharmaceuticals Inc. today announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline. “Over the past year, in anticipation of .
COVID-19 demand leads to Australian shortages of rheumatoid arthritis drug
We’re sorry, this service is currently unavailable. Please try again later.
Dismiss
Normal text size
Advertisement
Australia is facing shortages of a rheumatoid arthritis drug that has been used to treat COVID-19 overseas, with supply expected to be constrained into next year.
Pharmaceuticals giant Roche has warned the Therapeutic Goods Administration (TGA) that the pandemic has restricted supply of a variety of medicines under the brand name Actemra.
Australia is dangerously dependent on imports for its stocks of medicines.
Credit:Getty Images
Actemra is used to treat a conditions including giant cell arthritis and rheumatoid arthritis, as well as cytokine release syndrome, a systemic inflammatory disease which can be prompted by some cancer treatments.
Officials stress importance of COVID-19 vaccinations as cases increase amarillo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from amarillo.com Daily Mail and Mail on Sunday newspapers.